DossierENTITY

RAS-targeted cancer therapies

Coverage of RAS-targeted cancer therapies in the Nexus archive.

Earliest in view: Jul 8 · 06:00 UTCMost recent: Jul 8 · 06:00 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 8 · 06:00 UTCSCMP WORLD
China’s biotech firms challenge US with rapidly developing RAS-targeted cancer therapies
Chinese biotech firms are developing RAS-targeted cancer therapies that challenge U.S. companies like Revolution Medicines, whose drug improved survival for pancreatic cancer patients. Analysts note Chinese rivals are undervalued despite rapid progress in this competitive field.